[DISCLOSURE] Cell Biotech (049960) said on Sept. 5 that it has acquired a patent for a composition that prevents and treats inflammatory bowel disease, based on four kinds of probiotics lactic acid bacteria that the company owns.
By Park Yuna ()
[DISCLOSURE] Cell Biotech (049960) said on Sept. 5 that it has acquired a patent for a composition that prevents and treats inflammatory bowel disease, based on four kinds of probiotics lactic acid bacteria that the company owns.
By Park Yuna ()
Editor’s picks
more
More from Headlines